James Hsiao is a local partner in our White Collar practice, based in Hong Kong. He has over 10 years of experience in international anti-corruption investigations, regulatory and compliance matters, complex cross-border and commercial litigation, international arbitration, anti-money laundering, and risk management across Asia and globally.
James regularly represents companies, investors and individuals in connection with internal investigations and enforcement actions, including anti-bribery and anti-corruption actions such as FCPA related investigations, fraud, embezzlement, trade/sanctions, compliance audits and risk assessments, development of compliance policies and programs, and pre-transaction / pre-investment due diligence. He also conducts comprehensive compliance trainings for clients. His practice includes advising multinational and Asia-based companies in the finance, life science, biotech, pharmaceutical and technology sectors on a range of matters.
Before joining the White Collar team, James worked at international law firms in Hong Kong, New York and Los Angeles. He is a former prosecutor and has spent time on a client secondment at an American multinational investment bank and financial services company. James also has more than 7 years of experience working in various engineering roles at a number of technology start-ups and companies prior to law school.
James' experience* includes representing:
- a U.S.-listed life sciences company to conduct multiple internal investigations into allegations of distributor fraud, bribery, employee embezzlement, and sample misuse across a variety of jurisdictions, including Australia, China, Japan, Malaysia, and South Africa.
- a U.S.-listed industrial conglomerate to conduct internal investigation into allegations of revenue recognition fraud and falsification of documentation in a China-based subsidiary.
- a British life sciences company in landmark anti-bribery investigation in multiple jurisdictions (China, U.S., U.K.); conducted extensive internal investigations into China operations in connection with the same.
- a number of individuals in a joint U.S. DOJ/OFAC/BIS investigation into alleged violations of U.S. trade sanctions by a Chinese telecom company.
- a U.S.-listed China-based e-commerce company to conduct a financial fraud internal investigation regarding allegations of accounting and securities fraud by a short-seller.
- a multinational U.S.-listed medical device company in connection with its DOJ-appointed compliance monitorship; represented the company in presentations with the DOJ-appointed monitor.
- a multinational U.S.-listed company in an international arbitration at the HKIAC involving a dispute with a Chinese battery supplier.
- an individual defendant before the SEC regarding allegations of insider trading.
- a major British investment bank in state and federal securities lawsuits relating to residential mortgage-backed securities.
* Includes experience prior to joining White & Case
The War on Cybercrime: How Far Can You Go?, Corporate Counsel (April 2013), Co-author